The relationship between polyadenylation and splicing was investigated in a model system consisting of two tandem but nonidentical polyomavirus late transcription units. This model system exploits the polyomavirus late transcription termination and polyadenylation signals, which are sufficiently weak to allow the production of many multigenome-length primary transcripts with repeating introns, exons, and poly(A) sites. This double-genome construct contains exons of two types, those bordered by 3' and 5' splice sites (Li and L2) and those bordered by a 3' splice site and a poly(A) site (Vi and V2 In a number of recent studies involving different systems, evidence has been presented that alternate poly(A) site selection can be associated with different 3' splice site choices (5, 21, 22, 29, 38 ; see references 39, 42, and 53 for reviews). These studies have most often been done with complex transcription units which have multiple exons, introns, and poly(A) signals. In such systems, alternative pathways of pre-mRNA processing involve either cell-specific (9, 10, 21) or temporal (23, 42, 52) regulation of poly(A) site or splice site selection. One example of cell-specific regulation is the switch between secreted and membrane forms of the immunoglobulin M heavy chain. Studies have suggested that this switch is regulated at the level of poly(A) site choice (21, 29, 34, 41, 49) . Thus, in the immunoglobulin M system, choice of alternative poly(A) signals may lead to altered splicing pathways. Some recent results, however, have been inconsistent with such a model of poly(A) site dominance and have instead suggested that there may be competition between splicing and polyadenylation (44, 45). In contrast, the expression of calcitonin and the calcitoningene related peptide, also controlled in a cell-specific manner from a complex transcription unit containing two poly(A) sites, clearly appears to be regulated at the step of splice site recognition, which in turn leads to the use of the nearest downstream poly(A) signal (10, 22, 38 ).
In a number of recent studies involving different systems, evidence has been presented that alternate poly(A) site selection can be associated with different 3' splice site choices (5, 21, 22, 29, 38 ; see references 39, 42 , and 53 for reviews). These studies have most often been done with complex transcription units which have multiple exons, introns, and poly(A) signals. In such systems, alternative pathways of pre-mRNA processing involve either cell-specific (9, 10, 21) or temporal (23, 42, 52) regulation of poly(A) site or splice site selection. One example of cell-specific regulation is the switch between secreted and membrane forms of the immunoglobulin M heavy chain. Studies have suggested that this switch is regulated at the level of poly(A) site choice (21, 29, 34, 41, 49) . Thus, in the immunoglobulin M system, choice of alternative poly(A) signals may lead to altered splicing pathways. Some recent results, however, have been inconsistent with such a model of poly(A) site dominance and have instead suggested that there may be competition between splicing and polyadenylation (44, 45) . In contrast, the expression of calcitonin and the calcitoningene related peptide, also controlled in a cell-specific manner from a complex transcription unit containing two poly(A) sites, clearly appears to be regulated at the step of splice site recognition, which in turn leads to the use of the nearest downstream poly(A) signal (10, 22, 38) .
An example of temporal regulation of pre-mRNA processing occurs in the human adenovirus major late transcription unit (8, 42, 52) . At different times after infection, different mRNA species arising from the same transcriptional promoter are seen. Late in infection there are five distinct late mRNA families (8, 23, 25, 52) . Each family contains three to seven mRNAs, due to the use of different 3' splice sites (12, 19, 42) , and each family is associated with the use of a * Corresponding author. different late poly(A) site (Li to L5). This differs from early in infection, when only the Li poly(A) site is used efficiently (8, 52) .
We have studied the relationship between splice site and poly(A) site choice in a model system based on the polyomavirus late transcription unit. Like the systems described above, polyomavirus late primary transcripts are complex, with pre-mRNA processing involving the choice of alternative splice sites and poly(A) sites. The major difference between this system and others is that the polyomavirus late splice sites and poly(A) sites chosen during processing are identical to those that are skipped. Therefore, this is a simpler system, as differences in results cannot be ascribed to processing signals of different sequence.
Inefficient polyomavirus late-transcription termination and polyadenylation leads to the production of a heterogeneous collection of late primary transcripts in infected cells, some of which are many times the size of the viral genome (1-3, 56, 57) . These transcripts contain two types of exons, noncoding (leader) exons and message body exons. A leader exon occurs at the 5' end of every late transcript. In multigenome-length transcripts, this exon appears multiple times. During RNA processing, leaders splice to each other, skipping message body splice sites and removing genomelength introns. In addition, a message body 3' splice site is chosen to attach the final late leader exon to a terminal coding exon. Thus, the 5' ends of mature late-cytoplasmic messages contain between 1 and 12 tandem copies of the late leader exon, followed by a single coding exon (32, 33, 40, 55) . We have studied a series of double-genome constructs designed to produce late viral pre-mRNAs with multiple, identical poly (A) (24, 28) . The nucleotide sequence of this strain is very similar to that published for strain A3 (20) . Plasmid p43.25.67 is wild-type polyomavirus strain A2 with an XhoI linker at the PvuII site at nucleotide (nt) 5128, inserted at the BamHI site into pAT153 (58) , and was generously provided by A. Cowie and R. Kamen. All recombinant plasmids used here were propagated in Escherichia coli JM83.
Cell culture and transfections. Mouse NIH 3T3 cells were obtained from the American Type Culture Collection. The techniques for their propagation and transfection have been described elsewhere (14) . Briefly, all transfections were performed by using a modification of the calcium-phosphate transfection procedure of Chen and Okayama (16 Mg2+ and Ca2+), and RNA was harvested by the protocol described elsewhere (32) . Briefly, cells were scraped into PBS-and pelleted by centrifugation at 1,000 x g for 3 min. The pellet was resuspended in PBS and centrifuged again at 1,000 x g for 3 min. The cell pellet was resuspended in 3 ml of Nonidet P-40 lysis buffer and left on ice for 10 min. Nuclei were removed by centrifugation at 1,000 x g for 3 min. To the supematant (the cytoplasmic RNA fraction) was added 1.42 g of guanidine thiocyanate. RNA was separated from DNA by centrifugation through a 5.7 M cesium chloride cushion for 20 h at 110,000 x g (18) . The pelleted RNAs were drained well and resuspended in 300 ,ul of 10 mM Tris-Cl, pH 7.0-1 mM EDTA, pH 7.0-0.2% sodium dodecyl sulfate and ethanol precipitated. RNAs were resuspended in 100 ,ul of double-distilled H20.
Construction of plasmids. The structures of the major plasmids used in this study and the construction of probes are shown schematically in Fig. 1 (58) . The numbering system used in this paper can be converted to that of the A3 strain (20) by subtracting six nucleotides. The SLM leader exon (51 bp) is shown as a solid box, and the wild-type (WT) leader exon (57 bp) is the white box. Thick solid bars denote sequences deleted in the construction of plasmids pl-13, pl-11, pI-liSmA, pl-16, and pl-17. In the final clones, the SLM/MP8 and wild-type leader exons are renamed Li and L2, respectively, and the full-length and truncated VP1 exons are renamed Vi and V2, respectively. (B) Probes used for ribonuclease protection assays. Dotted lines denote sequences deleted in the construction of the truncated V2 exon and probes PP1 and PP3. PP1 is colinear with the V2 exon and its flanking sequences. PP3 is colinear with sequences in pl-11. (C) Schematic diagram of the major constructs used in this study. Before transfection, each was digested with EcoRl, which liberated the polyomavirus sequences from the plasmid backbone, and recircularized by using T4 DNA ligase. pI-13 contains two copies of the polyomavirus late region, but the first copy has a substituted late leader exon sequence (Li) (6), while the second has a truncated VP1 coding exon (V2). pl-11 is the same as pl-13, except for a 771-bp deletion spanning the first poly(A) site, with 441 nt downstream of the AAUAAA signal removed. pl-16 is the same as pl-13, except for deletion of sequences including one intact early coding region, replication origin, late promoter, and late leader exon. pl-17 is wild-type polyomavirus with a 1.6-kb duplication of sequences surrounding the late poly(A) site but containing no additional 3' splice site.
protected bands were resolved on 6% polyacrylamide-urea sequencing gels.
PCR assays. Oligonucleotide (oligo) primers were made by using a Biosearch Cyclone DNA Synthesizer and the phosphoramidite chemistry. Oligo 275 (5'-TATCACCGTACAG CCTTG) anneals across the VP1-late leader splice junction, with the terminal three bases annealing to the late leader and the rest annealing to the VP1 coding exon. Oligo 278 (5'-CCTGACATTTTCTATTTTAAG) anneals to late cDNA molecules immediately upstream of the late leader exon.
Oligo 279 (5'-TCCTAGATGAAAATGGAG) anneals to the truncated V2 exon but not to the wild-type Vi exon.
The polymerase chain reaction (PCR) (51) In all experiments, viral genomes were excised from the vector, recircularized by dilute ligation, and transfected into mouse NIH 3T3 cells. Cytoplasmic RNAs were harvested after 48 h and were analyzed by using T2 ribonuclease protection assays or PCR.
Vl and V2 exons can be skipped during pre-mRNA processing. Cytoplasmic RNAs from wild-type polyomavirus and constructs 1-13, I-li, and 1-16 were examined for exon skipping by a PCR assay (32) . Figure 2 shows the results of such an experiment using oligo 275, which binds to the junction of any Li or L2 exon spliced to any Vi or V2 exon.
PCR of the wild-type RNA described above provided size markers for 1 and 2 tandem L2 leader units. As transcription could initiate from either of the two late promoters in 1-13
and I-11 ( Fig. 1 In the 1-13 and I-11 lanes the upper band is intermediate in size from that representing two tandem Li exons (lane [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] or two tandem L2 exons (lane Py), indicating that the shorter Li had spliced to wild-type-length L2. Thus, Li and L2 exons can splice to each other in long primary transcripts, with a terminal splice to a body exon. Interestingly, the results seen with I-11 and 1-13 demonstrate that Li and L2 exons are not skipped during pre-mRNA splicing (only the intermediate size band observed), while Vi and V2 exons are. Note that the band marked L1-L2 in lanes 1-13 and I-11 includes molecules with the structure L2-L1-V1 and L1-L2-V2. These result from transcripts initiating at either promoter. In other PCR experiments using oligonucleotide primers specific for either the Vi or V2 exon, both L1-L2-V2 and L2-L1-V1 structures have been confirmed (data not shown). From these results, the constructs studied appear to provide a simple and convenient system in which to study how exon skipping and splice site selection occur in vivo.
Unused poly(A) sites are not found in mature messages. No wild-type spliced polyomavirus late messages have ever been observed that contain internal unused poly(A) sites. In order to determine whether this was also the case for construct 1-13, we analyzed messages from wild-type (polyomavirus) and 1-13 transfections by using an RNase T2 protection assay and probe PP4, which spans the poly(A) site (Fig. 3) band of 67 nt, which ran off the gel shown in Fig. 3 (Fig. 3, Vi RT) . Likewise, messages which contained an unused poly(A) site immediately downstream of the V2 exon (Fig. 3, V2 RT) would give a band of 441 nt. These messages were not detected. Taken together with the PCR results shown in Fig.  2 Fig.   4A . Results using probe PP2, which scores for Ll-to-Vl splicing, demonstrate that splicing to the first Vi exon does, in fact, occur in about 70% of the molecules (as determined by using a Betagen Betascope Blot Analyzer). The remaining 30% largely represents use of the minor, alternative VP3 3' splice site, just as we see with wild-type viral RNA (Fig. 1  and data not shown) .
Further analysis of these I-11 RNAs indicated that they contain sequences extending past the poly(A) site deletion, all the way to the next leader exon (L2). This was demonstrated by an RNase protection assay using probe PP3, which binds to RNA sequences downstream of the Vi 3' splice site (Fig. 4A) . About half of these RNAs contain an additional splice, mostly L2 to V2 (data not shown). Further analysis of both the splicing and the 3'-end structures surrounding the V2 exon in I-11 was done by using probe PP1 (Fig. 4A) . The 81-nt band represented splicing to the V2 3' splice site, while the 1%-nt band mostly represented molecules that contain L2 splices to the alternative VP3 3' splice site. In addition, no molecules were detected that included sequences downstream of the poly(A) site (445-, 560-nt bands), illustrating that construct I-11, like 1-13, had no unused poly(A) sites in mature messages. These results with I-11 indicated clearly that Vl 3' splice site choice can occur even when the nearby downstream poly(A) site has been removed.
Sequences downstream of the poly(A) site do not signal RNA degradation. The I-11 construct contains a large deletion of the poly(A) site (355 bp upstream of the AAUAAA signal and essentially all downstream sequences before the next genome). Therefore, the unusual message structures found in I-11 might result from the removal of sequences downis stream of the poly(A) site that otherwise might serve as a degradation signal of RNAs containing them. In order to test this, a construct with a much smaller poly(A) site deletion, M-liSmA, was made. In this construct the deletion removed only the AAUAAA signal and 20 downstream bases, most or all of which are retained in mature, polyadenylated messages. This deletion destroys late polyadenylation (lla). Cytoplasmic RNA made from this construct was compared with wild-type RNA in an RNase protection assay which detected early spliced species (as an internal control for transfection efficiencies and RNA amounts) and late Vispliced species. Such an assay has been reported in other work from our laboratory (4, 7) . The results are shown in Fig. 4B . RNAs containing the Vi splice (protected band of 203 nt) are as abundant as wild type when normalized to the band intensities for the early species. This again demonstrates that poly(A) site choice is not needed for Vi 3 A relationship exists between 3' splice site selection and poly(A) site choice. If poly(A) site choice does not influence splice site choice, and if the sequences downstream of the poly(A) site do not serve as degradation signals, why do we fail to observe these sequences in spliced Vi exons in 1-13 messages? One remaining possibility is that 3' splice site selection influences poly(A) site choice. In order to investigate this possibility, we examined message structures in I-17, which contains a large (1.6-kb) duplication of the late 3' processing and polyadenylation region (Fig. 1) . 3'-end analysis by an RNase protection assay demonstrated that cytoplasmic messages from this construct were all processed at the upstream poly(A) site (420-nt band, Fig. SA) . A 792-nt band representing molecules containing an unused poly(A) site [indicating use of the downstream poly(A) site] was not seen. PCR analysis (Fig. 5B) , however, showed that this construct generated messages with multiple L2 exons at their 5' ends, indicating that transcription could continue past both poly(A) sites. Choice of the first poly(A) site in constructs containing duplicated polyadenylation signals is influenced by the distance between the two signals. Lanoix et al. (37) showed that in polyomavirus mutant ins4, which had a 144-nt duplication of the late poly(A) signal (including 51 nt upstream and 87 nt downstream of the AAUAAA sequence), both poly(A) sites were used almost equally. This is likely the result of interference between the two sites. We have carried out an extensive analysis of the spacing requirements for poly(A) site choice in this system, with the results to be presented elsewhere (40a) . In that work we found that the first poly(A) site was chosen almost exclusively whenever the separation between the two sites was greater than about 150 nt.
Finally, in order to investigate further the relationship between splice site selection and downstream poly(A) site Fig. 2 and 6B) . Results of the PCR assay shown in Fig. 6B 53) . In some of these, regulated recognition and use of polyadenylation sites may allow alternative splicing choices to be made. In other cases, regulation is at the level of splice site choice, which in turn is associated with alternate poly(A) site use. In all of these systems, the sequences of the splice sites and poly(A) sites are different; as a result, these differences might affect site selection via a variety of mechanisms. The model system we describe also exhibits alternative poly(A) site and splice site selection. This system is different, however, in that the sites chosen are indistinguishable from the sites that are ignored.
In constructs 1-13 and I-li, Li and L2 exons splice sequentially to one another and are rarely skipped. However, Vi and V2 exons are frequently skipped. Skipping of Vi and V2 exons is almost certainly not the result of inefficient recognition of their 3' splice sites. In work to be presented elsewhere (40a), we have investigated the effects of different splice site and poly(A) site sequences on VP1 exon skipping in an otherwise wild-type polyomavirus backbone. Replacing the VP1 3' splice site with the late leader 3' splice site had no effect on the frequency of exon skipping. Rather, VP1 exon skipping could be eliminated either by replacing the normal poly(A) site with an efficient one or by placing a 5' splice site between the VPI 3' splice site and the poly(A) site.
The selection of a Vi or V2 3' splice site appears to be associated with the use of the nearest available downstream poly(A) site, even though transcription can proceed past identical, far-downstream poly(A) signals ( Fig. 5 and 6 ). This association results in no unused poly(A) signals in messages from wild-type polyomavirus or any of the constructs examined here (Fig. 3 to 6 ). One possible explanation for these observations would be that choice of a poly(A) site might commit a transcript to a particular splicing pathway. In this model, Li and L2 exons splice sequentially to each other in multigenome-length primary transcripts, removing any internal Vi or V2 3' splice sites. Only after such splicing commitments were made could splicing to Vi or V2 exons occur. If this were true, constructs I-11 and I-lSmA, which remove an internal poly(A) signal, would only produce mature messages that are spliced at the V2 3' splice site. This was not observed (Fig. 4) . Thus, poly(A) site choice (transcript length) cannot be the primary determinant of the splicing pathway. Results with I-11 and I-llSmA (Fig. 4) also rendered unlikely the possibility that sequences downstream of the poly(A) site might trigger RNA degradation, and they showed that the Vi splice site can be selected independently of the poly(A) site.
Two models can account for all of the results presented here. The first is a 3'-end limit-processing model. In the above model, 3' splice site recognition is the initial event of terminal exon definition and might also be important for the subsequent use of the poly(A) site. Results from I-11 and I-llSmA clearly demonstrate that Vi 3' splice site choice can be independent of poly(A) site choice; this site can be used whether or not a poly(A) site is positioned immediately downstream of it. However, it is nevertheless quite possible that use of this splice site still requires the recognition of a downstream RNA processing signal. In I-11 and I-lSmA, the Vi 3' splice site might be functionally paired with a downstream leader 5' splice site, which allows the recognition of the Vl exon as an internal rather than as a terminal exon.
Poly(A) site use in our system appears to be related to selection of the upstream 3' splice site. As the results from 1-17 show, only the poly(A) site nearest to the 3' splice site is normally used, even though transcription proceeds past both. This is also consistent with a 5' to 3' searching mechanism. If the exon definition model is correct, we predict that insertion of a 3' splice site between two poly(A) sites in a primary transcript should allow the previously unused downstream poly(A) site to be chosen. This is what we see when we compare the mRNAs produced by constructs I-17 and 1-16, and it again illustrates the dominance of 3' splice choice over poly(A) site choice.
In the exon definition model, both borders of an exon must be recognized in order for either to be available for RNA processing. If the 3' border of an exon [either a 5' splice site or a poly(A) site] were recognized inefficiently, then the upstream 3' splice site would also be ignored, leading to exon skipping. In our system, results from 1-13 clearly show that there is no spliced Vl or V2 exon with an unused poly(A) site downstream. This means that the choice of the Vl or V2 3' splice site is coupled to the use of the nearest downstream poly(A) site. The intrinsic weakness of the polyomavirus late poly(A) site would explain why Vi and V2 are often skipped in the constructs studied here. In the absence of a poly(A) site to define the terminal exon, a further downstream 5' splice site (such as the L2 leader 5' splice site in the long tail of some I-11 messages) can be used instead. This explains what we observed in I-11. Thus, in order for proper splicing and polyadenylation to occur, both a terminal 3' splice site (here Vi or V2) and a polyadenylation site must normally be chosen coordinately.
Finally, we speculate that the simplicity of the polyomavirus-based system described here has allowed us to uncover an underlying relationship between 3' splice site choice and poly(A) site use that might exist in a number of transcription units. Only when both choices are made can either process normally be completed. In different systems, regulation might occur at either border of an alternative terminal exon.
